Joseph H Antin Selected Research

Cytokine Release Syndrome

1/2023	Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.
1/2022	Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome.
1/2021	COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph H Antin Research Topics

Disease

102	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 10/2002
46	Bronchiolitis Obliterans Syndrome 01/2023 - 04/2004
33	Neoplasms (Cancer) 01/2023 - 08/2003
25	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 09/2003
24	Leukemia 01/2024 - 01/2004
23	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2024 - 09/2003
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 09/2003
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 03/2002
12	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2022 - 02/2010
11	Aplastic Anemia (Anemia, Hypoplastic) 09/2022 - 05/2007
11	Infections 01/2022 - 07/2002
11	Lymphoma (Lymphomas) 01/2021 - 07/2007
5	Iron Overload 08/2014 - 05/2007
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2006
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019 - 01/2016
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019 - 03/2009
3	Cytopenia 05/2024 - 12/2020
3	Cytokine Release Syndrome 01/2023 - 01/2021
3	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2019
3	Bronchiolitis Obliterans 12/2022 - 02/2012
3	Viremia 01/2022 - 05/2010
3	Thrombotic Microangiopathies 01/2020 - 07/2005
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2017 - 04/2008
3	Mycoses (Diseases, Fungus) 09/2012 - 05/2006
3	Multiple Myeloma 12/2011 - 12/2004
3	Pneumonia (Pneumonitis) 10/2008 - 12/2002
2	Hematologic Diseases (Blood Diseases) 01/2023 - 10/2002
2	Injection Site Reaction 12/2022 - 11/2017
2	Hematuria 11/2022 - 12/2020
2	Hypotension (Low Blood Pressure) 11/2022 - 03/2016
2	Virus Diseases (Viral Diseases) 01/2020 - 06/2013
2	Inflammation (Inflammations) 01/2018 - 10/2008
2	Fibrosis (Cirrhosis) 01/2017 - 02/2012
2	Exanthema (Rash) 02/2014 - 03/2011
2	Colitis 08/2013 - 09/2011
2	Disease Progression 12/2011 - 02/2010
2	Acute Lung Injury 10/2008 - 12/2002
2	Mucositis 05/2005 - 05/2004

Drug/Important Bio-Agent (IBA)

28	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 09/2003
25	Sirolimus (Rapamycin)FDA Link 01/2020 - 09/2003
20	Methotrexate (Mexate)FDA LinkGeneric 01/2024 - 09/2003
16	SteroidsIBA 01/2023 - 08/2004
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 09/2003
11	fludarabineIBA 02/2024 - 04/2008
11	Interleukin-2 (IL2)IBA 11/2022 - 12/2011
9	Busulfan (Busulfex)FDA Link 02/2024 - 12/2002
9	Calcineurin InhibitorsIBA 01/2019 - 05/2004
8	VaccinesIBA 12/2022 - 02/2003
8	AntigensIBA 01/2018 - 04/2004
7	defibrotideIBA 10/2018 - 07/2010
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 09/2022 - 06/2013
6	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 09/2004
6	Bortezomib (Velcade)FDA Link 03/2019 - 10/2009
5	trans-crotonin (CTN)IBA 09/2022 - 12/2011
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 05/2009
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021 - 05/2009
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 07/2006
5	Proteins (Proteins, Gene)FDA Link 07/2016 - 10/2008
5	Minor Histocompatibility AntigensIBA 03/2010 - 01/2003
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2022 - 09/2009
4	CytokinesIBA 01/2022 - 11/2002
4	IronIBA 11/2021 - 06/2011
4	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2012
3	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 12/2014
3	AntibodiesIBA 12/2017 - 04/2005
3	HLA-A Antigens (HLA-A)IBA 09/2015 - 04/2009
3	Ferritins (Ferritin)IBA 08/2014 - 06/2011
3	B-Cell Activating FactorIBA 05/2014 - 10/2007
3	Rituximab (Mabthera)FDA Link 06/2013 - 07/2006
2	venetoclaxIBA 01/2024 - 12/2021
2	Alemtuzumab (Campath)FDA Link 01/2023 - 05/2013
2	Abatacept (Orencia)FDA Link 01/2023 - 01/2018
2	IpilimumabIBA 10/2021 - 07/2016
2	Natalizumab (Tysabri)FDA Link 05/2021 - 01/2021
2	InterferonsIBA 12/2020 - 01/2016
2	ibrutinibIBA 01/2020 - 11/2014
2	Phosphotransferases (Kinase)IBA 01/2020 - 12/2008
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Monoclonal AntibodiesIBA 01/2017 - 09/2003
2	Immune Checkpoint InhibitorsIBA 01/2017 - 07/2016
2	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 02/2012
2	TOR Serine-Threonine KinasesIBA 12/2008 - 09/2004
2	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 08/2004
2	Polysaccharides (Glycans)IBA 03/2005 - 02/2003

Therapy/Procedure

89	Hematopoietic Stem Cell Transplantation 01/2024 - 07/2002
59	Transplantation 11/2023 - 03/2002
57	Therapeutics 01/2024 - 01/2002
44	Stem Cell Transplantation 02/2024 - 04/2002
36	Cell Transplantation 05/2024 - 02/2003
15	Homologous Transplantation 01/2023 - 11/2003
11	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2022 - 03/2002
10	Drug Therapy (Chemotherapy) 01/2021 - 10/2006
6	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2016 - 05/2004
4	Immunotherapy 01/2024 - 01/2006
3	Aftercare (After-Treatment) 01/2014 - 01/2010
2	Salvage Therapy 09/2022 - 12/2019
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2019
2	Chemoradiotherapy 01/2018 - 05/2005